Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease

Archives of Neurology

Volumn 56, Issue 2, 1999, Pages 179-187

  Hauser, Robert A ^a,b   Freeman, Thomas B ^b   Snow, Barry J ^b   Nauert, Michael ^c   Gauger, Lisa ^d   Kordower, Jeffrey H ^e   Olanow, C Warren ^f  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Women's Center   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA; LEVODOPA;

ADULT; ARTICLE; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; FEMALE; FETAL TISSUE TRANSPLANTATION; FETUS; FOLLOW UP; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; MALE; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL; REINNERVATION; TREATMENT OUTCOME;

ADULT; EVALUATION STUDIES; FEMALE; FETAL TISSUE TRANSPLANTATION; FOLLOW-UP STUDIES; FUNCTIONAL LATERALITY; GRAFT SURVIVAL; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; SUBSTANTIA NIGRA; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033053030     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.56.2.179     Document Type: Article

References (83)

1. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington: clinical, morphological and neurochemical correlations. J Neural Sci. 1973:20:415-455.
2. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease: pathophysiologic and clinical implications. N Engl J Med. 1988;318:876-880.
3. Bjorklund A, Stenevi U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 1979:177:555-560.
4. Freed WJ, Perlow MJ, Karoum F, et al. Restoration of dopamine function by grafting of fetal substantia nigra to the caudate nucleus: long term behavioral, biochemical and historical studies. Ann Neurol. 1980:8:510-522.
5. Sladek JR Jr, Collier TC, Haber SN, Roth RH, Redmond DE Jr. Survival and growth of fetal catecholamine neurons transplanted into the primate brain. Brain Res Bull. 1986;17:809-818.
6. Clarke DJ, Brundin P, Strecker R, Nilsson 0, Bjorklund A, Lindvall O. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp Brain Res. 1988:73:115-126.
7. Arbuthnott G, Dunnett SD, MacLeod N. Electrophysiological properties of single units in dopamine-rich mesencephalic transplants in rat brain. NeurosdLett. 1985; 57:205-210.
8. Perlow MJ, Freed WJ, Hoffer BJ, Seiger A, Olson L, Wyatt RJ. Brain grafts reduce motor abnormalities produced by destruction of the nigrostriatal dopamine system. Science. 1979:204:643-645.
9. Dunnett SB, Bjorklund A, Stenevi U, Iverson SO. Behavioral recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway, I: unilateral lesions. Brain Res. 1981:215:147.
10. Redmond DE Jr, Sladek JR Jr, Roth RH, Collier TJ, Deutch AY, Haber SN. Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet. 1986; 1:1125-1127.
11. Annett LE, Martel FL, Rogers DC, Ridiey RM, Baker HF, Dunnett SB. Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6OHDA lesions of the nigrostriatal pathway. Exp Neurol. 1994:125:228-246.
12. Lindvall 0, Rehncrona S, Brundin P, et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. Arch Neurol. 1989:46:615-631.
13. Lindvall 0, Brundin P, Widner H, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science. 1990:247:574-577.
14. Lindvall 0, Widner H, Rehncrona S, et al. Transplantation of fetal dopamine neurons in Parkinson's disease. Ann Neurol. 1992;31:155-165.
15. Lindvall 0, Sawle G, Widner H, et al. Evidence of long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol. 1994; 35:172-180.
16. Freed CR, Breeze RE. Rosenberg NL, et al. Transplantation of human fetal dopamine ceils for Parkinson's disease: results at 1 year. Arch Neurol. 1990:47:505-512.
17. Freed CR, Breeze RE, Rosenberg ML, et al. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. NEnglJMed. 1992;327:1549-1555.
18. Spencer DD, Robbins RJ, Naflolin F, et al. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. NEnglJMed. 1992:327:1541-1548.
19. Peschanski M, Defer G, N'Guyen JP, et al. Bilateral motor improvement and alteration of l-dopa effect in too patients with Parkinson's disease following intrastriatal transplantation of fetal ventral mesencephalon. Brain. 1994;117: 487-499.
20. Kopyov 0V, Jacques DS, Lieberman A, Duma C, Rogers RL Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson's disease. Cell Transplant. 1996:5:327-337.
21. Widner H, Tetrud J, Rehncrona S, et al. Bilateral mesencephalic grafting in too patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine (MPTP). NEnglJMed. 1992:38:1556-1563.
22. Olanow CW, Kordower JH, Freeman TB. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 1996:19:102-109.
23. Freeman TB, Olanow CW, Hauser RA, et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann fJeurol. 1995; 38:379-388.
24. Längsten JW, Widner H, Goetz CG, et al. Core Assessment Program for Intracerebral Transplantations (CAPIT). MovDisord. 1992;7:2-13.
25. Nauert GM, Freeman TB. Low pressure aspiration abortion for obtaining embryonic and early gestational fetal tissue for research purposes. Cell Transplant. 1994; 3:147-151.
26. O'Rahilly R, Muller F. Developmental Stages in Human Embryos: Including a Revision ofStreeter's "Horizons" and a Survey of the Carnegie Collection. Washington, DC: Carnegie Institution of Washington; 1987.
27. Drumm JE, O'Rahilly RO. The assessment of prenatal age from the crown-rump length determined ultrasonically. Am JAnat. 1977:148:555-560.
28. Hern WM. Correlation of fetal age and measurements between 10 and 26 weeks of gestation. Obstet Gynecol. 1984:63:26-32.
29. Freeman TB, Spence MS, Boss BD, et al. Development of dopaminergic neurons in the human substantia nigra. ExpNeurol. 1991:113:344-353.
30. Freeman TB, Sandberg PR, Nauert GM, et al. Influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral grafts. Cell Transplant. 1995;4:141-154.
31. Freeman TB, Kordower JH. Human cadaver embryonic substantia nigra grafts: effects of ontogeny, preoperative graft preparation and tissue storage. In: Lindvall 0, Bjorklund A, Widner H, eds. Intracerebral Transplantation in Movement Disorders. Amsterdam, the Netherlands: Elsevier Science Publishers; 1991:163-169.
32. Suva LCE, Brimacombe JR. The laryngeal mask airway for stereotactic implantation of fetal hypophysis. AnesthAnalg. 1996;82:426-439.
33. Breeze RE, Wells TH, Freed CR. Implantation of fetal tissue for the management of Parkinson's disease: a technical note. Neurosurgery. 1995:36:1044-1048.
34. Freeman TB, Brandeis L, Pearson J, Noonan RA, Michael JP. Ontogeny of mesencephalic tyrosine hydroxylase immunoreactive neurons in the brain of the farm pig. Soc Neurosci Abs. 1986:12:1223.
35. Vingerhoets FJG, Snow BJ, Schulzer M, et al. Reproducibility of fluorine-18-6fluorodopa positron emission tomography in normal human subjects. JNuclMed. 1994:35:18-24.
36. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations. JCereb Blood Flow Metab. 1985:5:584-590.
37. Kordower JH, Freeman TB, Snow BJ, et al. Neuropathological evidence of graft survival and striatal reinnervation after transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. W EnglJMed. 1995;332:1118-1124.
38. Kordower JH, Rosenstien JM, Collier TJ, et al. Functional fetal nigral grafts in two patients with Parkinson's disease. Am Soc Neural Transplant. 1996;3:16.
39. Vingerhoets FJG, Schulzer M, Snow BJ. Reproducibility of the fluorodopa positron emission tomography indices in Parkinson's disease. Mov Disord. 1994:9:119.
40. Snow BJ, Vingerhoets FJG, Hauser RA, Freeman TB, Olanow CW. PET studies of bilateral fetal nigral transplantation for Parkinson's disease. MovDisord. 1996; 11(suppl1):250.
41. Kordower JH, Rosenstein JM, Collier TJ, et al. Functional fetal nigral grafts in a patient with Parkinson's disease. J Comp Neurol. 1996:370:203-230.
42. Wenning GK, Odin P, Morrish P, et al. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol. 1997;42:95-107.
43. Cenci MA, Kalen P, Duan WM, Bjorklund A. Transmitter release from transplants of fetal ventral mesencephalon or locus coeruleus in the rat frontal cortex and nucleus accumbens. Brain Res. 1994;2:225-248.
44. Widner H, Rehncrona S, Snow B, et al. Neural grafting into a L-dopa untreated, severely MPTP-lesioned patient. MovDisord. 1996;11(suppl 1):249.
45. Pearce RKB, Jackson M, Smith L, Jenner P, Marsden CD. Chronic L-dopa administration induces dyskinesias in the 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine-treated common marmoset (Callithrix Jacchus). MovDisord. 1995;10:731-740.
46. Mouradian MM, Heuser IJE, Baronti F, Chase TN. Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease. Ann Neural. 1990:27:18-23.
47. Remy P, Samson Y, Hantraye P, et al. Clinical correlates of [18F]fluorodopa uptake in five parkinsonian patients. Ann Neural. 1995:38:580-588.
48. Bortongan CV, Freeman TB, Hauser RA, Cahill DW, Sanberg PR. Cyclosporine-A increases locomotor activity in rats with 6-hydroxydopamine-induced hemiparkinsonism: relevance to neural transplantation. Surg Neural. 1996:46:384-388.
49. Wesselborg S, Prüfer U, Wild M, Schraven B, Mever SC, Kabelfe D. Triggering via the alternative CD2 pathway induces apoptosis in activated human T lymphocytes. EurJImmunol. 1993:23:2707-2710.
50. Lindvall O. Prospects of transplantation in human neurodegenerative diseases. Trends Neurosci. 1991:14:376-384.
51. Brundin P, Strecker RE, Clarke DJ, et al. Can human fetal dopamine neuron grafts provide a therapy for Parkinson's disease? Prog Brain Res. 1988;78: 441-448.
52. Schultzberg M, Dunnett SB, Bjorklund A, et al. Dopamine and cholecystokinin immunoreactive neurons in mesencephalic grafts reinnervating the neostriatum: evidence for selective growth regulation. Neuroscience. 1984:12:17-32.
53. Sauer H, Fischer W, Nikkhah G, et al. Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts. Brain Res. 1993:626:37-44.
54. Johansson M, Friedemann M, Hoffer B, Stromberg I. Effects of glial cell linederived neurotrophic factor on developing and mature ventral mesencephalic grafts in oculo. ExpNeurol. 1995:134:25-34.
55. Takayama HJ, Ray Ramon HK, Baird A, Hogg J, Fisher LJ, Gage FH. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. NatMed. 1995;1:53-58.
56. Yurek DM, Lu TAW, Hipkins S, Wiegand SJ. BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Exp Neurol. 1996; 137:105-118.
57. Sanberg PR, Borlongan CV, Saporta S, et al. Transplantation of testis-derived sertoli cells into the brain. Cell Transplant. 1996;5(suppl 2):39.
58. Nakao N, Frodl EM, Widner H, et al. Overexpressing Cu/Zn Superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nat Med. 1995:1:226-231.
59. Nakao N, Frodl EM, Duan WM, Widner H, Brundin P. Lazaroids improve the survival of grafted rat embryonic dopamine neurons. ProcNatlAcadSciUSA. 1994; 91:12408-12412.
60. Rosenbald C, Martinez-Serranno A, Bjorklund A. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience. 1996:75:979-985.
61. Othberg AJ, Cameron DF, Anton A, Shah RC, Saporta S, Sanberg P. Evidence for a direct trophic effect of porcine sertoli cells on rat fetal dopaminergic neurons in vitro. Am Soc Neural Transplant. 1997;6:27.
62. Bjorklund A, Stenevi U, Dunnett SB, Iverson SD. Functional reactivation of the deafferented neostriatum by nigral transplants. Nature. 1981:289:497-499.
63. Henderson BTH, Clough CG, Hughes RC, Hitchcock ER, Kenny BG. Implantation of human ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease. Arch Neurol. 1991:48:822-827.
64. Inoue H, Kohsaka S, Yoshida K, et al. Cyclosporin A enhances the survivability of mouse cerebral cortex grafted into the third ventricle of rat brain. Neurosci Lett. 1985:54:85-90.
65. Nicholas MK, Antel JP, Stefansson K, Amason BGW. Rejection of fetal neocortical neural transplants by H-2 incompatible mice. J Immunol. 1987:139: 2275-2283.
66. Freed CR, Trojanowski JQ, Calvin JE, et al. Embryonic dopamine cells cultured as strands show long term survival without immunosuppression in a patient with advanced Parkinson's disease. Soc Neurosci Abs. 1997:23:1682.
67. Kordower JH, Styren S, Clarke M, Dekosky ST, Freeman TB, Olanow CW. Fetal grafting for Parkinson's disease. Cell Transplant. 1997:6:213-219.
68. Steece-Collier K, Yurek DM, Collier TJ, Sladek JR Jr. Neuropharmacological interactions of levodopa and dopamine grafts. In: Lindvall 0, Bjorklund A, Widner H, eds. Intracerebral Transplantation in Movement Disorders: Experimental Basis and Clinical Experiences. Amsterdam, the Netherlands: Elsevier Science Publishers; 1991:325-331.
69. Yurek DM, Steece-Collier K, Collier TJ, Sladek JR Jr. Chronic levodopa impairs the recovery of dopamine agonist-induced rotational behavior following neural grafting. Exp Brain Res. 1991:86:97-107.
70. Walkinshaw G, Waters CM. Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. JClin Invest. 1995:95:2458-2464.
71. Szabo J. Organization of the ascending striatal afférents in monkeys. J Comp Neural. 1980:189:307-321.
72. Brooks DJ, Ibanez V, Sawle GV, etal. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neural. 1990:28:547-555.
73. Kunzle H. Bilateral projections from precentral motor cortex to the putamen and other parts of the basal ganglia. Brain BehavEvol. 1975:88:195-209.
74. Alexander GE, Crutcher MD, DeLong MR. Basal gangia-thalamocortical circuits. Prog Brain Res. 1990;85:119-146.
75. Agid Y, Javoy-Agid F, Ruberg M. Biochemistry of neurotransmitters in PD. In: Marsden CD, Fahn S, eds. Movement Disorders 2. Newton, Mass: ButterworthHeinemann; 1987:166-230.
76. Dunnett SB, Bjorklund A, Schmidt RH, Stenevi U, Iversen SD. Intracerebral grafting of neuronal of neuronal cell suspensions, IV. Acta Physiol Scand (Suppl). 1983:522:29-37.
77. Dunnett SB, Bjorklund A, Stenevi U, Iversen SD. Grafts of embryonic substantia nigra reinnervating the ventrolateral striatum ameliorate sensorimotor impairments and akinesia in rats with 6-OHDA lesions of the nigrostriatal pathway. Brain Res. 19B1;229:209-217.
78. Dunnett SB, Annett LE. Migrai transplants in primate models of parkinsonism. In: Lindvall 0, Bjorklund A, Widner H, eds. Intraceretiral Transplantation in Movement Disorders: Experimental Basis and Clinical Experiences. Amsterdam, the Netherlands: Elsevier Science Publishers; 1991:27-51.
79. Annett LE, Torres EM, Ridley RM, Baker HF, Dunnett SB. A comparison of the behavioral effects of embryonic nigral grafts in the caudate nucleus and in the putamen of marmosets with unilateral 6-OHDA lesions. Exp Brain Res. 1995; 103:355-371.
80. Imai H, NakamuraT, Endo K, Narabayashi H. Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyI-1,2,3,6tetrahydropyridine (MPTP). Brain Res. 1988;474:327-332.
81. Hitchcock E. Current trends in neural transplantation. NeurolRes. 1995:17:3337.
82. Brundin P, Strecker RE, Londos E, Bjorklund A. Dopamine neurons grafted unilaterally to the nucleus accumbens affect drug-induced circling and locomotion. Exp Brain Res. 1987;69:183-194.
83. Nikkah G, Bentlage C, Cunningham MG, Bjorklund A. Intranigral fetal dopamine grafts induce behavioral compensation in the rat parkinsonian model. J Neurosci. 1994;14:3449-3461.